Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
August 6th, 2020
7.2K views
We show the automation of human induced pluripotent stem cell (hiPSC) cultures and neuronal differentiations compatible with automated imaging and analysis.
Overview
This study demonstrates automated procedures for culturing and differentiating human induced pluripotent stem cells (hiPSCs) into neuronal lineages, along with their automated imaging. The implementation of standardized automated protocols minimizes experimental variation while maintaining high phenotypic reproducibility.
Key Study Components
Research Area
- Human induced pluripotent stem cells (hiPSCs)
- Neuronal differentiation
- Automation in cell culture
Background
- hiPSCs are vital for understanding human development and disease.
- Automated systems enhance the reliability and efficiency of cell culture processes.
- Neuronal differentiation from hiPSCs can be applied in neuroscience research and drug development.
Methods Used
- Automated cell culture techniques
- Human induced pluripotent stem cells (hiPSCs)
- Brightfield imaging for confluency assessment and automated confocal microscopy for imaging
Main Results
- Automated differentiation results in neurons with morphology and network organization similar to manually cultivated neurons.
- Expressed specific neuronal markers critical for maturation and functionality.
- Established a live cell automated neurite outgrowth assay with no manual intervention, enabling longitudinal studies.
Conclusions
- This automated system facilitates reproducible hiPSC culture and neuronal differentiation.
- It holds potential for advancing biological research and therapeutic applications in neuroscience.
Frequently Asked Questions
What are human induced pluripotent stem cells?
Human induced pluripotent stem cells are versatile cells capable of differentiating into various cell types, making them crucial for biomedical research.
How does automation benefit cell culture?
Automation reduces human error, increases reproducibility, and allows for high-throughput experiments in cell culture.
What markers are used to assess neuronal differentiation?
Neuronal markers such as class III beta-tubulin, microtubule-associated protein 2, and synapsin I are used to validate neuronal differentiation.
Can the automated system be adapted for new protocols?
Yes, the system is designed to be flexible and can accommodate the development of new experimental protocols.
What technologies are employed in the imaging process?
Brightfield imaging and automated confocal microscopy are utilized for imaging cellular confluency and neuronal morphology.
What advantages does this system offer for neuroscience research?
It enables high-throughput analysis and consistent generation of neuronal cultures, facilitating studies on neurodevelopment and disease.
Executive Industry Relevance
Manual hiPSC differentiation suffers from high variability and labor-intensive workflows, limiting scalability for target validation and phenotypic screening. Automated culture and imaging systems reduce experimental variation, enhance reproducibility, and enable high-throughput compound, RNAi, and CRISPR/Cas9 screening. This supports predictive confidence in early discovery by providing disease-relevant neuronal models with consistent morphology and marker expression.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses using NGN2-over-expression for rapid cortical neuron production within 6–8 days.
- Scientific Value: Supports functional validation of dopaminergic neuron targets via long-term differentiation over 65 days with expected morphology and organization.
- Operational Value: Reduces mechanistic ambiguity by minimizing spontaneous differentiation and variability across hiPSC lines.
Screening & Assay Development
- Scientific Value: Establishes a live-cell automated neurite outgrowth assay for longitudinal measurement over 11 days without manual intervention.
- Operational Value: Integrates high-content imaging via Brightfield and confocal microscopy for quantitative phenotypic readouts.
- Operational Value: Supports scalable screening formats for neurodegeneration-relevant assays such as TDP-43 translocation and alpha-synuclein fibril uptake.
Translational & Preclinical Research
- Scientific Value: Provides disease-relevant cortical and dopaminergic neuron models for mechanistic de-risking in neurodegenerative disease models.
- Operational Value: Ensures translational continuity from discovery through preclinical validation via standardized, reproducible differentiation.
- Strategic Value: Enables risk-adjusted advancement decisions by delivering consistent neuronal phenotypes for target and pathway validation.
Pipeline & Workflow Integration
The automated system supports a discovery continuum from early target validation through lead identification to preclinical assessment by delivering reproducible neuronal cultures suitable for multi-modal screening.
- Discovery Biology: Facilitates hypothesis testing and pathway clarification via rapid, marker-confirmed cortical and dopaminergic neuron differentiation.
- Screening: Delivers assay readiness and reproducibility through automated plating, media changes, and confluency monitoring in 384-well formats.
- Analytics: Enables quantitative measurements of neurite outgrowth, marker expression, and phenotypic changes over time via integrated live-cell imaging.
- Translational Research: Supports preclinical continuity by generating dopaminergic neurons with expected cellular organization for disease modeling.
- Enterprise Reuse: Functions as a reusable platform for parallel hiPSC line maintenance and adaptation to new protocols including CRISPR/Cas9 and RNAi screening.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through reduced variability and high phenotypic reproducibility in neuronal differentiation.
- Operational Value: Standardization and scalability via automated seeding, media exchange, and environmental controls.
- Strategic Value: Improved go/no-go decisions by enabling large-scale screening with consistent neuronal outputs.
- Portfolio Impact: Risk-adjusted prioritization through reliable disease-relevant models for target validation and lead identification.
Implementation Considerations
- Requires expertise in stem cell culture, automation programming, and image analysis workflows.
- Dependent on integrated liquid handling, incubation, and confocal/Brightfield imaging infrastructure.
- Necessitates cross-team standardization for batch tracking, plate ID management, and protocol reproducibility.
- Involves adaptation considerations for different hiPSC lines and differentiation protocols including small molecule-derived precursors.
- Practical limitations include system setup complexity and validation needs for new assay integration.
Biopharma FAQs
Why does confluency assessment matter for target validation in hiPSC cultures?
Confluency assessment via Brightfield imaging ensures consistent starting cell densities, which is critical for reproducible differentiation outcomes and reduces variability in target validation experiments.
How does isolating the NGN2 overexpression variable support the discovery pipeline?
By using NGN2-over-expression as a controlled independent variable, the system enables rapid, synchronized cortical neuron production within 6–8 days, supporting hypothesis testing in early discovery.
What quantitative neurite outgrowth measurements enable lead identification?
Automated live-cell imaging allows longitudinal measurement of neurite lengths over 11 days, providing quantitative phenotypic data to compare compound effects in screening campaigns.
Why are replication requirements important for cross-functional collaboration in automated differentiation?
Replication across multiple hiPSC lines and batches ensures data reliability, enabling confident handoff between discovery, assay development, and preclinical teams.
What statistical analysis capabilities are required before implementing high-throughput neuronal screening?
The system requires image-based quantification tools and normalization methods to analyze marker expression and neurite metrics across plates, enabling robust statistical comparison of screening hits.
Chapters in this video
0:05
Introduction
0:43
New Culture Plate and Tip Loading and Decontamination
1:35
Culture Medium and/or Dissociation Reagent Filling
2:09
Automated Method Execution
2:51
Human Induced Pluripotent Stem Cell (hiPSC) Seeding
4:09
Automated Confluence Assessment
4:47
Medium Change
5:37
Subcultivation
6:42
Automated High Content, High Throughput Imaging
7:14
Results: Representative Automated System-Produced hiPSC-Derived Cortical and Dopaminergic Neuron Characterization
8:58
Conclusion
